Verticals

Blast Overpressure & Brain Injury

Blast exposure remains an important focus of military brain-health research. GLIA Diagnostics is investigating whether circulating miRNA biomarkers can provide complementary biological information following blast and other head-injury exposures, with the longer-term objective of translating this biology toward rapid point-of-care assessment.

Blast Overpressure as a Cause of TBI

Blast overpressure (BOP) is an important mechanism of potential brain injury in military training and operational environments. Blast exposure can involve primary pressure-wave effects as well as secondary, tertiary and other mechanisms of injury.

The biological consequences of blast exposure can be difficult to assess, particularly following mild TBI or repeated low-level exposure. This has created significant research interest in objective biomarkers capable of complementing clinical, cognitive and operational assessments.

Blast TBI: The Numbers

Major Research Focus

Blast-related brain health remains an important area of military and Defence research.

Evaluated

GLIA’s biomarkers have been evaluated in Defence-relevant and blast-exposure research, supporting further investigation of potential operational applications.

Repeated Exposure

Repeated low-level blast exposure is an important area of research, including investigation of potential cumulative biological effects.

The Diagnostic Gap

Why Blast TBI Is So Hard to Detect

Conventional imaging may be normal following mTBI, while symptom-based and cognitive assessments can be influenced by timing, context and operational factors. This creates an important need to investigate complementary objective biological measures.

GLIA is investigating whether circulating miRNA patterns can provide complementary biological information following blast and other head-injury exposures. These applications remain investigational and require further analytical and clinical validation.

GLIA's Solution

Investigating PoC Biomarkers for Blast Exposure

Objective Blast Injury Signal

GLIA’s biomarkers have been evaluated in Defence-relevant and blast-exposure research. Further work is investigating whether the panel can provide objective biological information associated with responses to blast exposure and TBI.

Field-Ready Platform

GLIA NeuroTESTA is being developed toward a portable point-of-care format intended ultimately for environments where conventional laboratory infrastructure may be limited. Final operational applications remain subject to development and validation.

Cumulative Exposure Monitoring

GLIA is investigating the behaviour of its miRNA biomarkers following repeated low-level blast exposure, including whether serial measurement may provide useful information about biological response and recovery.

RTD Decision Support

Future studies will investigate whether serial biological measurements could complement established clinical and operational assessments used in return-to-duty (RTD) decision-making. This potential application has not yet been clinically validated.

Integration with Military Protocols

The intended role of GLIA’s technology is to complement established military concussion and brain-health assessment pathways by adding objective biological information where clinically and operationally appropriate.

Longitudinal Recovery Tracking

Serial testing may offer a future opportunity to investigate biological change over time following blast or other head-injury exposure. GLIA is evaluating this longitudinal potential through ongoing research.

Explore further

Developing Objective Biomarker Tools for Operational Settings

GLIA Diagnostics is developing objective biomarker technologies intended ultimately to complement brain-injury assessment in military and operational environments. These applications remain investigational and require further validation.

Explore Our Biomarkers